Mylan is target of 2 probes, has 3Q loss due to EpiPen fine

The maker of EpiPen emergency allergy injectors, under a microscope for jacking up the price for the life-saving device repeatedly, reveals Wednesday evening that it’s a target of two different price-related probes by federal agencies

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s